A preliminary score for the assessment of disease activity in hereditary recurrent fevers: Results from the AIDAI (Auto-Inflammatory Diseases Activity Index) consensus conference

Annals of the Rheumatic Diseases

Volumn 70, Issue 2, 2011, Pages 309-314

  Piram, Maryam ^a   Frenkel, Joost ^b   Gattorno, Marco ^c   Ozen, Seza ^d   Lachmann, Helen J ^e   Goldbach Mansky, Raphaela ^f   Hentgen, Véronique ^g   Neven, Bénédicte ^h   Stojanovic, Katia Stankovic ⁱ   Simon, Anna ^j   Kuemmerle Deschner, Jasmin ^k   Hoffman, Hal ^l   Stojanov, Silvia ^m   Duquesne, Agnès ⁿ   Pillet, Pascal ^o   Martini, Alberto ^c   Pouchot, Jacques ^p   Koné Paut, Isabelle ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF GENOA   (Italy)

^d HACETTEPE UNIVERSITY   (Turkey)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^g CENTRE HOSPITALIER DE VERSAILLES   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ HÔPITAL TENON   (France)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^l RADY CHILDREN'S HOSPITAL   (United States)

^m LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁿ HOSPICES CIVILS DE LYON   (France)

^o BORDEAUX UNIVERSITY HOSPITAL   (France)

^p HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; MEVALONATE KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; AUTOINFLAMMATORY DISEASE; BOUTONNEUSE FEVER; CHILD; CINCA SYNDROME; CLINICAL ARTICLE; CONSENSUS DEVELOPMENT; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MEVALONATE KINASE DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SCORING SYSTEM; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

EID: 78751688718     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.132613     Document Type: Article

References (25)

1. Touitou I, Koné-Paut I. Autoinflammatory diseases. Best Pract Res Clin Rheumatol 2008;22:811-29.
2. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009;360:2416-25.
3. Hoffman HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes:results from two sequential placebo-controlled studies. Arthritis Rheum 2008;58:2443-52.
4. Sinha I, Jones L, Smyth RL, et al. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 2008;5:e96.
5. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001;345:1748-57.
6. Batthish M, Schneider R, Ramanan AV, et al. What does "active disease"mean? patient and part5ent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA). Rheumatology (Oxford) 2005;44:796-9.
7. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9.
8. Ruperto N, Meiorin S, Iusan SM, et al. Consensus procedures and their role in pediatric rheumatology. Curr Rheumatol Rep 2008;10:142-6.
9. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-80.
10. Zulian F, Woo P, Athreya BH, et al. The Pediatric Rheumatology European Society/ American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007;57:203-12.
11. Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever:literature review and consensus statement. Pediatrics 2007;119:e474-83.
12. Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612-27.
13. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
14. Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes:evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006;18:108-17.
15. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey:results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1-11.
16. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009;48:395-8.
17. van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 2008;87:301-10.
18. DodéC, AndréM, Bienvenu T, et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002;46:2181-8.
19. Aksentijevich I, D Putnam C, Remmers EF, et al. The clinical continuum of cryopyrinopathies:novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007;56:1273-85.
20. Singh JA, Solomon DH, Dougados M, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-52.
21. Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61:658-66.
22. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64. (Pubitemid 41111472)
23. Pras E, Livneh A, Balow JE, Jr, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75:216-9.
24. Ozen S, Aktay N, Lainka E, et al. Disease severity in children and adolescents with familial Mediterranean fever:a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246-8.
25. Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-9.